Erythroplasia of Queyrat treated with topical 5-fluorouracil

Erythroplasia of Queyrat treated with topical 5-fluorouracil*

We report a 33-year-old male patient diagnosed with erythroplasia of Queyrat. The patient had an erythematous and eroded lesion affecting more than 50% of the glans associated with bleeding and local pain. Despite previous indication of penectomy, he was successfully treated with topical 5-fluorouracil.

Erythroplasia of Queyrat =جسنتلا رمحألا تاريكل ERYTHROPLASIA OF QUEYRAT

Erythroplasia of Queyrat =جسنتلا رمحألا تاريكل ERYTHROPLASIA OF QUEYRAT

Erythroplasia of Queyrat

A 58-year-old Caucasian male presented to the urology clinic reporting an approximate one-year history of a persistent irritating, slowly progressive, glans penis redness. Biopsy revealed penile squamous cell carcinoma in situ. He underwent a partial glansectomy with circumcision and skin grafting. At three months follow-up there is no evidence of local disease recurrence. In western countries,...

A case of erythroplasia of queyrat treated with imiquimod 5% cream and excision.

Imiquimod is a new immunomodulating agent with antitumor and antiviral properties that has been shown to be clinically effective in various kinds of skin diseases, including precancerous dermatoses. Erythroplasia of Queyrat is a carcinoma in situ that mainly occurs on the glans penis. There are several non-invasive treatment options for erythroplasia of Queyrat such as photodynamic therapy, cry...